Stockreport

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Neumora Therapeutics, Inc.  (NMRA) 
PDF WATERTOWN, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline [Read more]